Follow
James McFadyen
James McFadyen
Unknown affiliation
Verified email at monash.edu
Title
Cited by
Cited by
Year
The emerging threat of (micro) thrombosis in COVID-19 and its therapeutic implications
JD McFadyen, H Stevens, K Peter
Circulation research 127 (4), 571-587, 2020
6132020
Current and future antiplatelet therapies: emphasis on preserving haemostasis
JD McFadyen, M Schaff, K Peter
Nature Reviews Cardiology 15 (3), 181-191, 2018
2592018
Platelet-derived microvesicles in cardiovascular diseases
MTK Zaldivia, JD McFadyen, B Lim, X Wang, K Peter
Frontiers in cardiovascular medicine 4, 74, 2017
1572017
Dissociation of C-reactive protein localizes and amplifies inflammation: evidence for a direct biological role of C-reactive protein and its conformational changes
JD McFadyen, J Kiefer, D Braig, J Loseff-Silver, LA Potempa, ...
Frontiers in immunology 9, 1351, 2018
1482018
Platelets are not just for clots
JD McFadyen, ZS Kaplan
Transfusion medicine reviews 29 (2), 110-119, 2015
1262015
The class II PI 3-kinase, PI3KC2α, links platelet internal membrane structure to shear-dependent adhesive function
JK Mountford, C Petitjean, HWK Putra, JA McCafferty, NM Setiabakti, ...
Nature communications 6 (1), 6535, 2015
852015
Thrombin-dependent intravascular leukocyte trafficking regulated by fibrin and the platelet receptors GPIb and PAR4
ZS Kaplan, A Zarpellon, I Alwis, Y Yuan, J McFadyen, M Ghasemzadeh, ...
Nature communications 6 (1), 7835, 2015
712015
C-reactive protein and its structural isoforms: an evolutionary conserved marker and central player in inflammatory diseases and beyond
JD McFadyen, J Zeller, LA Potempa, GA Pietersz, SU Eisenhardt, K Peter
Vertebrate and invertebrate respiratory proteins, lipoproteins and other …, 2020
682020
Neutrophil macroaggregates promote widespread pulmonary thrombosis after gut ischemia
Y Yuan, I Alwis, MCL Wu, Z Kaplan, K Ashworth, D Bark Jr, A Pham, ...
Science Translational Medicine 9 (409), eaam5861, 2017
672017
Bortezomib-based antibody depletion for refractory autoimmune hematological diseases
S Ratnasingam, PA Walker, H Tran, ZS Kaplan, JD McFadyen, H Tran, ...
Blood Advances 1 (1), 31-35, 2016
662016
Differentiating haemostasis from thrombosis for therapeutic benefit
JD McFadyen, SP Jackson
Thrombosis and haemostasis 110 (11), 859-867, 2013
642013
Targeting activated platelets: a unique and potentially universal approach for cancer imaging
ML Yap, JD McFadyen, X Wang, NA Zia, JD Hohmann, M Ziegler, Y Yao, ...
Theranostics 7 (10), 2565, 2017
522017
Thromboembolic and bleeding complications in transcatheter aortic valve implantation: insights on mechanisms, prophylaxis and therapy
MP Ranasinghe, K Peter, JD McFadyen
Journal of Clinical Medicine 8 (2), 280, 2019
472019
Clinical care of pregnant and postpartum women with COVID‐19: Living recommendations from the National COVID‐19 Clinical Evidence Taskforce
JP Vogel, B Tendal, M Giles, C Whitehead, W Burton, S Chakraborty, ...
Australian and New Zealand Journal of Obstetrics and Gynaecology 60 (6), 840-851, 2020
452020
Compression force sensing regulates integrin αIIbβ3 adhesive function on diabetic platelets
L Ju, JD McFadyen, S Al-Daher, I Alwis, Y Chen, LL Tønnesen, ...
Nature communications 9 (1), 1087, 2018
442018
Lysophosphatidylcholine is a major component of platelet microvesicles promoting platelet activation and reporting atherosclerotic plaque instability
P Diehl, F Nienaber, MTK Zaldivia, J Stamm, PM Siegel, NA Mellett, ...
Thrombosis and Haemostasis 119 (08), 1295-1310, 2019
412019
Novel antithrombotic drugs on the horizon: the ultimate promise to prevent clotting while avoiding bleeding
JD McFadyen, K Peter
Circulation Research 121 (10), 1133-1135, 2017
392017
Activated platelets in the tumor microenvironment for targeting of antibody-drug conjugates to tumors and metastases
ML Yap, JD McFadyen, X Wang, M Ziegler, YC Chen, A Willcox, ...
Theranostics 9 (4), 1154, 2019
382019
C-reactive protein, immunothrombosis and venous thromboembolism
C Dix, J Zeller, H Stevens, SU Eisenhardt, KSCT Shing, TL Nero, ...
Frontiers in immunology 13, 1002652, 2022
352022
Transitional changes in the structure of C-reactive protein create highly pro-inflammatory molecules: Therapeutic implications for cardiovascular diseases
J Zeller, B Bogner, JD McFadyen, J Kiefer, D Braig, G Pietersz, G Krippner, ...
Pharmacology & Therapeutics 235, 108165, 2022
302022
The system can't perform the operation now. Try again later.
Articles 1–20